12 comments
11 forecasters
What placebo-adjusted reduction in MADRS total score at Week 6 will be reported for MM120 (lysergide) vs. placebo in the Phase 3 Emerge trial in major depressive disorder?
Peer Score
community
-0.5
Average
of peers
Baseline Score
community
+6.1
0
Chance
baseline
Disagreement Score
41.73
JSD Disagreement Score
3.46
Panel forecasts
10
CDF
This chart shows all included forecasts that were active at scoring time.
Mantic
Forecast 1 of 10 - started Jun 18, 2026, 1:14 AM
Author:
Opened:Jun 18, 2026
Closes:Jun 18, 2026
Resolved:Jul 10, 2026
Spot Scoring Time:Jun 18, 2026
Include Bots:Yes